Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs

Today, 2:02 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22)

ACOR

12 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For July 20, 2021

By Benzinga Insights

Today, 2:02 AM

AHAC

1 minute read

Wedbush Initiates Coverage On Elevation Oncology with Outperform Rating, Announces Price Target of $27

By Benzinga Newsdesk

Today, 2:02 AM

Wedbush analyst Robert Driscoll initiates coverage on Elevation Oncology (NASDAQ:ELEV) with a Outperform rating and announces Price Target of $27.

ELEV

1 minute read

Cowen & Co. Initiates Coverage On Elevation Oncology with Outperform Rating

By Benzinga Newsdesk

Today, 2:02 AM

Cowen & Co. analyst Marc Frahm initiates coverage on Elevation Oncology (NASDAQ:ELEV) with a Outperform rating.

ELEV

1 minute read

SVB Leerink Initiates Coverage On Elevation Oncology with Outperform Rating, Announces Price Target of $20

By Benzinga Newsdesk

Today, 2:02 AM

SVB Leerink analyst Andrew Berens initiates coverage on Elevation Oncology (NASDAQ:ELEV) with a Outperform rating and announces Price Target of $20.

ELEV

3 minute read

The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs

By Shanthi Rexaline

Today, 2:02 AM

Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears, and exerted negative pressure on stocks. There were very few stock-specific catalysts, barring a few preannouncements, stock offerings, and a slew of initial public offerings.

ABT